Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 19;25(1):148.
doi: 10.1186/s12886-025-03954-8.

High BMI, silicone oil tamponade, and recurrent vitreous hemorrhage predict poor visual outcomes after pars plana vitrectomy in proliferative diabetic retinopathy

Affiliations

High BMI, silicone oil tamponade, and recurrent vitreous hemorrhage predict poor visual outcomes after pars plana vitrectomy in proliferative diabetic retinopathy

Zhi-Gang Wang et al. BMC Ophthalmol. .

Abstract

Background: Proliferative diabetic retinopathy (PDR) is a serious microvascular complication of diabetes and a leading cause of global vision loss. Pars plana vitrectomy (PPV) is the primary surgical treatment for PDR, but visual outcomes vary due to multiple influencing factors. This study aims to evaluate the factors predicting visual prognosis in patients with PDR after PPV.

Methods: A retrospective analysis was performed on 112 eyes from 87 patients with PDR who underwent PPV between May 2020 and May 2024. Data collected included patient demographics, preoperative and postoperative best-corrected visual acuity (BCVA), and other baseline clinical data. Data analysis was performed with IBM SPSS Statistics Version 24.0. Univariate and multivariate linear regression models were applied to assess the relationship between the final BCVA and various clinical parameters.

Results: The mean BCVA improved significantly, from 1.94 ± 0.89 logMAR preoperative to 0.76 ± 0.70 logMAR postoperatively (P < 0.001). Multivariate linear regression identified body mass index (BMI) (B = 0.035; 95% CI 0.003-0.066; P = 0.033), silicone oil (SO) tamponade (B = 0.354; 95% CI 0.005-0.643; P = 0.029), and recurrent vitreous hemorrhage (VH) (B = 0.585; 95% CI 0.304-0.867; P < 0.001) as significant negative predictors of final BCVA.

Conclusions: While PPV improves visual outcomes in PDR patients, factors such as high BMI, SO tamponade, and recurrent VH negatively affect prognosis and could serve as predictors of poor visual outcomes following the procedure. This study emphasizes the importance of tailored management strategy for PDR, including early intervention, optimal BMI control, and minimizing SO tamponade duration.

Keywords: Body mass index (BMI); Pars plana vitrectomy (PPV); Predictive factors; Proliferative diabetic retinopathy (PDR); Silicone oil (SO); Visual outcomes; Vitreous hemorrhage (VH).

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study adhered to the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Hefei Aier Eye Hospital (Approval No. 202212). Written informed consent was obtained from all participants prior to their inclusion in the study. This study was conducted as a retrospective analysis using anonymized data. The requirement for informed consent was waived by the Hefei Aier Eye Hospital because the research involved no more than minimal risk to participants, and the use of identifiable data was not necessary for the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

References

    1. Thomas RL, Halim S, Gurudas S, Sivaprasad S, Owens DR. IDF diabetes atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018 [J]. Diabetes Res Clin Pract. 2019;157:107840. 10.1016/j.diabres.2019.107840 - PubMed
    1. Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis [J]. J Glob Health. 2018;8(1):010803. 10.7189/jogh.08.010803 - PMC - PubMed
    1. Yaow CY, Lin SY, Xiao J, Koh JH, Yong JN, Tay PW, Tan ST. A meta-analysis of prevalence of diabetic retinopathy in Asia [J]. Minerva Endocrinol (Torino). 2022. 10.23736/s2724-6507.21.03585-5 - PubMed
    1. Schreur V, Brouwers J, Van Huet RC, Smeets S, Phan M, Hoyng CB, De Jong EK, Klevering BJ. Long-term outcomes of vitrectomy for proliferative diabetic retinopathy [J]. Acta Ophthalmol. 2021;99(1):83–9. 10.1111/aos.14482 - PMC - PubMed
    1. Perais J, Agarwal R, Evans JR, Loveman E, Colquitt JL, Owens D, Hogg RE, Lawrenson JG, Takwoingi Y, Lois N. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy [J]. Cochrane Database Syst Rev. 2023;2(2):Cd013775. 10.1002/14651858.CD013775.pub2 - PMC - PubMed

MeSH terms

LinkOut - more resources